CHPG - CAS 170846-74-9

CHPG is a selective mGluR5 agonist that reduces LDH release and neuronal apoptosis, activates the ERK and Akt pathways, and protects against traumatic brain injury. It also increases the number of differentiated human OPCs and alleviates LPS-induced inflammation.

Akt, Dehydrogenase, NF-κB, ERK, GluR

Neuroscience, Cytoskeletal Signaling, MAPK, PI3K/Akt/mTOR signaling, NF-κB, Metabolism

170763

C8H8ClNO3

201.61

O=C(O)C(N)C1=CC(O)=CC=C1Cl

-20°C

Ice Packs

Small Compound